News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
319,574 Results
Type
Article (17255)
Company Profile (105)
Press Release (302214)
Section
Business (109315)
Career Advice (750)
Deals (19301)
Drug Delivery (71)
Drug Development (41125)
Employer Resources (67)
FDA (7066)
Job Trends (7263)
News (180541)
Policy (16255)
Tag
Academia (635)
Alliances (25805)
Alzheimer's disease (454)
Approvals (7080)
Artificial intelligence (95)
Bankruptcy (177)
Best Places to Work (5271)
Breast cancer (85)
Cancer (601)
Career advice (653)
Cell therapy (109)
Clinical research (34185)
Collaboration (307)
Compensation (121)
COVID-19 (941)
C-suite (109)
Data (574)
Diabetes (92)
Diagnostics (1884)
Drug pricing (64)
Earnings (42258)
Employer resources (59)
Events (44018)
Executive appointments (382)
FDA (7418)
Funding (243)
Gene therapy (99)
GLP-1 (362)
Government (1644)
Healthcare (5787)
Infectious disease (977)
Inflammatory bowel disease (62)
Interviews (93)
IPO (7744)
Job creations (2222)
Job search strategy (593)
Layoffs (204)
Legal (4041)
Lung cancer (81)
Manufacturing (149)
Medical device (3086)
Medtech (3089)
Mergers & acquisitions (11728)
Metabolic disorders (256)
Neuroscience (627)
NextGen: Class of 2025 (2242)
Non-profit (940)
Northern California (760)
Obesity (145)
Opinion (137)
Patents (81)
People (36013)
Pharmaceutical (66)
Phase I (9318)
Phase II (14680)
Phase III (12625)
Pipeline (324)
Policy (55)
Postmarket research (1478)
Preclinical (3662)
Radiopharmaceuticals (144)
Rare diseases (163)
Real estate (2945)
Regulatory (11353)
Research institute (750)
Resumes & cover letters (90)
Southern California (704)
Startups (1899)
United States (7201)
Vaccines (185)
Weight loss (108)
Date
Today (67)
Last 7 days (307)
Last 30 days (1348)
Last 365 days (15802)
2025 (1417)
2024 (15974)
2023 (17948)
2022 (24561)
2021 (25419)
2020 (23940)
2019 (18944)
2018 (14862)
2017 (16484)
2016 (15697)
2015 (18338)
2014 (14695)
2013 (12351)
2012 (13340)
2011 (13882)
2010 (12659)
Location
Africa (365)
Arizona (67)
Asia (23226)
Australia (3095)
California (1744)
Canada (919)
China (197)
Colorado (106)
Connecticut (69)
Europe (46203)
Florida (281)
Georgia (56)
Illinois (178)
Indiana (157)
Japan (68)
Kansas (56)
Maryland (310)
Massachusetts (1419)
Minnesota (102)
New Jersey (718)
New York (483)
North Carolina (394)
Northern California (760)
Pennsylvania (427)
South America (595)
Southern California (704)
Texas (251)
Virginia (58)
Washington State (105)
319,574 Results for "parnell pharmaceuticals holdings".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering
Parnell Pharmaceuticals Holdings Ltd announced the extension of the backstopped rights offering to raise gross proceeds of approximately US$4.0 million.
January 6, 2023
·
3 min read
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering
Parnell Pharmaceuticals Holdings Ltd commenced its previously announced backstopped rights offering to raise gross proceeds of approximately US$4.0 million.
December 6, 2022
·
4 min read
Deals
Parnell Pharmaceuticals Holdings Ltd Announces Proposed Rights Offering
Parnell Pharmaceuticals Holdings Ltd (OTC Pink ® Open Market: PARNF) (“Parnell”) announced its intention to raise US$4.0 million through a backstopped rights offering at no charge (the “Rights Offering”) for qualifying shareholders of record as of December 6, 2022 (the “Record Date”).
December 1, 2022
·
3 min read
Press Releases
Genflow Biosciences PLC Announces Holding(s) in Company - 2
January 13, 2025
·
2 min read
Press Releases
Genflow Biosciences PLC Announces Holding(s) in Company - 1
January 13, 2025
·
3 min read
Press Releases
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025
January 21, 2025
·
6 min read
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum
Parnell Pharmaceuticals Holdings Ltd, a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Friday, 15th July 2022 at 8:30 a.m..
June 21, 2022
·
2 min read
Press Releases
Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
January 21, 2025
·
5 min read
Press Releases
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
December 6, 2024
·
4 min read
BioCapital
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
June 6, 2024
·
3 min read
1 of 31,958
Next
